Related Experiment Video
Updated: Jan 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Jun Wan1, Samuel Block2, Christina M Scribano1
1Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Abstract:
Mitotic arrest deficient 1 (Mad1) plays a well-characterized role in the mitotic checkpoint. However, interphase roles of Mad1 that do not impact mitotic checkpoint function remain largely uncharacterized. Here we show that upregulation of Mad1, which is common in human breast cancer, prevents stress-induced stabilization of the tumor suppressor p53 in multiple cell types. Upregulated Mad1 localizes to ProMyelocytic Leukemia (PML) nuclear bodies in breast cancer and cultured cells. The C-terminus of Mad1 directly interacts with PML, and this interaction is enhanced by sumoylation. PML stabilizes p53 by sequestering MDM2, an E3 ubiquitin ligase that targets p53 for degradation, to the nucleolus. Upregulated Mad1 displaces MDM2 from PML, freeing it to ubiquitinate p53. Upregulation of Mad1 accelerates growth of orthotopic mammary tumors, which show decreased levels of p53 and its downstream effector p21. These results demonstrate an unexpected interphase role for Mad1 in tumor promotion via p53 destabilization.
Insights
Upregulated Mitotic Arrest Deficient 1 (Mad1) promotes breast cancer by preventing tumor suppressor p53 stabilization. Mad1 interacts with PML bodies, displacing MDM2 and leading to p53 degradation.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Mitotic Arrest Deficient 1 (Mad1) is known for its role in the mitotic checkpoint.
- Interphase functions of Mad1, independent of the mitotic checkpoint, are largely unknown.
- Mad1 upregulation is frequently observed in human breast cancers.
Purpose of the Study:
- To investigate the uncharacterized interphase roles of Mad1 in cancer.
- To determine how Mad1 upregulation affects tumor suppressor p53 stability.
- To elucidate the molecular mechanisms underlying Mad1's function in breast cancer.
Main Methods:
- Investigated Mad1 localization in breast cancer and cultured cells using immunofluorescence.
- Performed co-immunoprecipitation assays to study Mad1-PML and PML-MDM2 interactions.
- Utilized cell-based assays to assess p53 stabilization and ubiquitination.
- Generated orthotopic mammary tumor models to evaluate tumor growth in vivo.
Main Results:
- Upregulated Mad1 prevents stress-induced stabilization of the tumor suppressor p53.
- Mad1 localizes to ProMyelocytic Leukemia (PML) nuclear bodies and interacts with PML, an interaction enhanced by sumoylation.
- Mad1 displaces MDM2 from PML, leading to increased p53 ubiquitination and degradation.
- Mad1 upregulation accelerates mammary tumor growth and reduces p53 and p21 levels.
Conclusions:
- Mad1 has an unexpected interphase role in promoting tumors.
- Mad1 destabilizes p53 by interfering with the PML-MDM2 complex.
- Mad1 upregulation contributes to breast cancer progression through p53 pathway inhibition.
Related Concept Videos
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

